MedPath

A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty

Not Applicable
Completed
Conditions
Rheumatoid Arthritis
Osteoarthritis
Traumatic Arthritis
Avascular Necrosis
Interventions
Procedure: Metal on Metal cementless hip
Registration Number
NCT00757354
Lead Sponsor
Zimmer Biomet
Brief Summary

A clinical Evaluation to determine metal ion release from 4th generation metal-on-metal hip articulating surfaces in cementless total hip arthroplasty.

Detailed Description

This evaluation is being conducted to investigate the extent of metal ion release and its incorporation into the surrounding tissue resulting from metal on metal articulating surfaces in cementless total hip arthroplasty.

The amount of metallic ions released post operatively will be assessed by the concentration of Cobalt, Chromium and Molybdenum present in urine and analysed by I.C.P.M.S. (Inductive Coupled Plasma Mass Spectroscopy). The amounts of metallic ions released will be related to the hip function and range of motion measured pre-operatively and post-operatively. Secondary performance of the metal-on-metal articulation will be determined by radiographic evaluation and incidence of complications / revision rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • Subjects selected for this Evaluation will be grouped by initial diagnosis into one of the following diagnostic groups:

    • Non-inflammatory degenerative joint disease including osteoarthritis, avascular necrosis and traumatic arthritis.
    • Rheumatoid arthritis.
  • Selection of subjects for this Evaluation should include the following considerations:

    • Patients under 70 years of age.
    • Willing to return for follow-up evaluations.
    • No bias to sex.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Metal on Metal cementless hipMetal on Metal cementless hipMetal on Metal cementless hip arthroplasty
Primary Outcome Measures
NameTimeMethod
concentration of Cobalt, Chromium and Molybdenum ions in urinevarious follow-up visits
Secondary Outcome Measures
NameTimeMethod
harris Hip Score, oxford hip, WOMAC and SF-12various follow-up visits

Trial Locations

Locations (1)

Avon Orthopaedic Centre

🇬🇧

Bristol, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath